Search - tctmd.com

Displaying 81 - 100 of 912

Sort: Relevancy | Date

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Daily News

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

Caitlin E. Cox

October 11, 2022

News Conference News EACTS 2022

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Michael O'Riordan

October 07, 2022

News Daily News

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Michael O'Riordan

October 07, 2022

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Caitlin E. Cox

October 03, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

Shelley Wood

October 03, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

Shelley Wood

September 28, 2022

News Daily News

INOCA Exerts Heavy Toll on Daily Life: Survey

Caitlin E. Cox

September 28, 2022

News Daily News

Risk of Radiation Low for Pregnant Operators When Precautions Taken

Michael O'Riordan

September 27, 2022

News Conference News TCT 2022

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Yael L. Maxwell

September 27, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

Presentation TCT 2022

Con

Presenter: Nihar Desai

September 19, 2022

Presentation TCT 2022

Pro

Presenter: Babar Basir

September 19, 2022

Advertisement

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

TCTMD’s Top 10 Most Popular Stories for September 2022

October 2022 News Roundup

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

INOCA Exerts Heavy Toll on Daily Life: Survey

Risk of Radiation Low for Pregnant Operators When Precautions Taken

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Most Patient-Reported Outcome Measures in CVD Fall Short

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

Con

Pro

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content